Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial

Background. Intermittent application of chemotherapy and tyrosine kinase inhibitors may avoid antagonism between the two classes of drugs. This hypothesis was tested in a Phase II clinical trial. Patients and Methods. Eligible patients were nonsmokers or light smokers, chemo-naïve, with metastatic a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zwitter, Matjaz, Rajer, Mirjana, Kovac, Viljem, Kern, Izidor, Vrankar, Martina, Smrdel, Uros
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3085288/
https://ncbi.nlm.nih.gov/pubmed/21541241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/185646
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars